Document is current
Any future updates will be listed below
-
Authors
Weidenbacher, Payton A.-B. https://orcid.org/0000-0002-7692-0458
Waltari, Eric https://orcid.org/0000-0001-6930-9645
de los Rios Kobara, Izumi https://orcid.org/0000-0002-6479-110X
Bell, Benjamin N. https://orcid.org/0000-0001-5356-0173
Morris, Mary Kate
Cheng, Ya-Chen
Hanson, Carl
Pak, John E.
Kim, Peter S. https://orcid.org/0000-0001-6503-4541
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (DP1AI158125)
Foundation for the National Institutes of Health (DP1AI158125)
Foundation for the National Institutes of Health (DP1AI158125)
Foundation for the National Institutes of Health (DP1AI158125)
Virginia & D.K. Ludwig Fund for Cancer ResearchFrank Quattrone and Denise Foderaro Family Research Fund
Chan Zuckerberg Biohub
Virginia & D.K. Ludwig Fund for Cancer ResearchFrank Quattrone and Denise Foderaro Family Research FundChan Zuckerberg Biohub
- License Information
-
More Information
Article History
Received: 8 April 2022
Accepted: 10 August 2022
First Online: 8 September 2022
Competing interests
: P.A.-B.W., E.W. and P.S.K. are named as inventors on a provisional patent application applied for by Stanford University and the Chan Zuckerberg Biohub on coronavirus neutralizing compositions and associated methods. The remaining authors declare no competing interests.
